Insufficient inhibition of 4E-BP1 phosphorylation has been implicated in primary resistance against ATP-competitive mTORC1 inhibitors, suggesting that inactivated 4E-BP1 supports tumor growth [16]. This evidence concerns the gene EIF4EBP1 and neoplasm.